3-47062371-GTTTT-GTTT
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_014159.7(SETD2):c.6110-26delA variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★). There are indicators that this mutation may affect the branch point..
Frequency
Genomes: 𝑓 0.0035 ( 1 hom., cov: 0)
Exomes 𝑓: 0.050 ( 5 hom. )
Consequence
SETD2
NM_014159.7 intron
NM_014159.7 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.577
Genes affected
SETD2 (HGNC:18420): (SET domain containing 2, histone lysine methyltransferase) Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein belonging to a class of huntingtin interacting proteins characterized by WW motifs. This protein is a histone methyltransferase that is specific for lysine-36 of histone H3, and methylation of this residue is associated with active chromatin. This protein also contains a novel transcriptional activation domain and has been found associated with hyperphosphorylated RNA polymerase II. [provided by RefSeq, Aug 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 3-47062371-GT-G is Benign according to our data. Variant chr3-47062371-GT-G is described in ClinVar as [Benign]. Clinvar id is 1178301.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAdExome4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0703 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SETD2 | NM_014159.7 | c.6110-26delA | intron_variant | ENST00000409792.4 | NP_054878.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SETD2 | ENST00000409792.4 | c.6110-26delA | intron_variant | 5 | NM_014159.7 | ENSP00000386759.3 |
Frequencies
GnomAD3 genomes AF: 0.00351 AC: 514AN: 146620Hom.: 1 Cov.: 0
GnomAD3 genomes
AF:
AC:
514
AN:
146620
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0373 AC: 5517AN: 147998Hom.: 1 AF XY: 0.0387 AC XY: 3105AN XY: 80146
GnomAD3 exomes
AF:
AC:
5517
AN:
147998
Hom.:
AF XY:
AC XY:
3105
AN XY:
80146
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0503 AC: 55293AN: 1099224Hom.: 5 Cov.: 0 AF XY: 0.0502 AC XY: 27349AN XY: 544416
GnomAD4 exome
AF:
AC:
55293
AN:
1099224
Hom.:
Cov.:
0
AF XY:
AC XY:
27349
AN XY:
544416
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00352 AC: 516AN: 146672Hom.: 1 Cov.: 0 AF XY: 0.00301 AC XY: 215AN XY: 71316
GnomAD4 genome
AF:
AC:
516
AN:
146672
Hom.:
Cov.:
0
AF XY:
AC XY:
215
AN XY:
71316
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 20, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BranchPoint Hunter
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at